Specialized AI agents are moving from hype to practical use in drug discovery.
A new paper co-authored by Srijit Seal and the AIAgents4Science Consortium highlights case studies from Human Chemical, Coincidence Labs, Kiin Bio, and
@readysetpotato — showing faster workflows for toxicology, literature synthesis, protocol design, and discovery.
drugtargetreview.com/home/fr…
Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬
syntheticbiologysummit.com/2…